We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Ultrapotent Bispecific Antibodies That Can Simultaneously Bind to Two Different Antigens Neutralize SARS-CoV-2 Variants

By HospiMedica International staff writers
Posted on 15 Sep 2021
Print article
Illustration
Illustration
Researchers have developed bispecific antibodies - antibodies that can simultaneously bind to two different antigens - that target multiple regions of the SARS-CoV-2 spike protein and neutralize virus variants of concern.

The team of researchers from the National Institute of Allergy and Infectious Diseases (NIAID; Bethesda, MD, USA) isolated monoclonal antibodies targeting the SARS-CoV-2 spike protein from donors who had recovered from COVID-19. Pairs of potent monoclonal antibodies that bound distinct regions of the spike protein were combined into bispecific antibodies. These bispecific antibodies prevented SARS-CoV-2 variants of concern from infecting cells in vitro and prevented disease in hamsters infected with SARS-CoV-2.

Currently, COVID-19 antibody treatments work by sending in a cocktail of individual monoclonal antibodies to target various parts of the virus. However, the NIAID researchers showed that combining some of these monoclonal antibodies into a new bispecific antibody can create stronger antibodies that are more potent than the monoclonal cocktails - one bispecific antibody they tested, in particular, was 100 times more potent against the virus than a cocktail of its monoclonal parents.

Two of the bispecific antibodies neutralized the original virus as well as the Alpha, Beta, Gamma, and Delta variants. In hamsters infected with SARS-CoV-2, two of the bispecific antibodies protected the animals from clinical disease. The researchers developed the bispecific antibodies from a pool of 216 monoclonal antibodies that target SARS-CoV-2 from convalescent COVID-19 patients, screening them for potency against the virus. The bispecific antibodies may be especially effective against the variants because they bind to non-overlapping areas of the viral spike and have limited contact with areas on the spike where variant mutations have occurred.

“In the face of rapidly emerging SARS-CoV-2 variants that challenge our efforts to end the pandemic, our findings support the further exploration of bispecific antibodies that strategically combine antibody pairs as new tools to treat COVID-19,” stated Hyeseon Cho from the team of NIAID researchers.

Related Links:
NIAID

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bilirubin Lamp
Bilibluelight

Print article

Channels

Critical Care

view channel
Image: Researchers have developed an advanced shear-thinning hydrogel for aneurysm repair (Photo courtesy of TIBI)

New Hydrogel Features Enhanced Capabilities for Treating Aneurysms and Halting Progression

Aneurysms can develop in blood vessels in different body areas, often as a result of atherosclerosis, infections, inflammatory diseases, and other risk factors. These conditions lead to chronic inflammation,... Read more

Surgical Techniques

view channel
Image: The living replacement knee will be tested in clinical trials within five years (Photo courtesy of ARPA-H)

Living Knee Replacement to Revolutionize Osteoarthritis Treatment

Osteoarthritis is the most prevalent type of arthritis, characterized by the progressive deterioration of cartilage, or the protective tissue covering the bone ends, resulting in pain, stiffness, and impaired... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.